Edgewise Therapeutics share price logo

Edgewise Therapeutics

NASDAQ: EWTX

Mid Cap

$43.88

-0.29

(-0.66%)

Live

as on

Edgewise Therapeutics Stock Performance

as on August 18, 2026 at 6:32 am IST

  • Day's Low

    Day's High

    $42.77
    $43.98
    downward going graph

    2.53%

    Downside

    0.23%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $13.53
    $48.40
    downward going graph

    69.18%

    Downside

    10.30%

    Upside

    downward going graph

Edgewise Therapeutics share price movements today

Previous Close
$44.17
Open
$43.70
Volume
526.2K
Market Cap
$4.8B
Day's Low - High
$42.77 - $43.98
52 Week Low - High
$13.53 - $48.40

Edgewise Therapeutics Historical Returns

1 Month Return
+ 11.09 %
3 Month Return
+ 33.48 %
1 Year Return
+ 212.16 %
3 Year Return
+ 523.87 %
5 Year Return
+ 169.66 %

Edgewise Therapeutics Stock Fundamentals & Key Indicators

Check Edgewise Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.8B

EPS (TTM)

1.3944

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-216.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-38.03%

Edgewise Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Edgewise Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$4.8B169.66%NA0.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Edgewise Therapeutics Stock including INR - Dollar returns

The Edgewise Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Edgewise Therapeutics investment value today

Current value as on today

₹3,39,518

Returns

₹2,39,518

(+239.52%)

Returns from Edgewise Therapeutics Stock

₹2,10,106 (+210.11%)

Dollar Impact

₹29,412 (+29.41%)

Analyst Recommendation on Edgewise Therapeutics Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Edgewise Therapeutics. Average target price of $51.15

Edgewise Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Edgewise Therapeutics.

What analysts predicted

14.21%UPSIDE

Target Price

$51.15

Current Price

$43.88

Analyzed by

12 Analysts

Target

$51.15

Edgewise Therapeutics target price $51.15, a slight upside of 14.21% compared to current price of $43.88. According to 12 analysts rating.

Indian Investors' Interest in Edgewise Therapeutics Stock

Search interest for Edgewise Therapeutics Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

Edgewise Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
2
-
-
-
-
-
-
Gross Profit
0
0
-2
1
0
0
-
-
0
-
Operating Income
-34
-38
-40
-45
-45
-42
-46
-55
-54
-61
EBITDA
-28
-30
-33
-39
-40
-35
-40
-51
-48
-56
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-28
-31
-34
-39
-40
-36
-40
-50
-49
-57
Income Tax Expense
0
-
-
0
-
-
-
-
-
-
Net Income
-28
-31
-34
-39
-40
-36
-40
-50
-49
-57
Net Profit Margin
0.00%
0.00%
0.00%
-1872.62%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Edgewise Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-1
-2
-2
Operating Income
-9
-17
-43
-22
-114
-158
-191
EBITDA
-9
-17
-42
-21
-98
-131
-165
Interest Expense
-
0
0
4
-
-
-
Depreciation
0
0
0
0
1
2
2
Income Before Tax
-9
-17
-42
-19
-100
-133
-167
Income Tax Expense
0
0
0
-4
-
0
-
Net Income
-9
-17
-42
-15
-100
-133
-167
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Edgewise Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-31
-34
-39
-40
-36
-40
117
-49
-57
Operating Cash Flow
-26
-27
-26
-37
-32
-34
-38
-42
-43
Investing Cash Flow
37
25
20
43
-162
35
49
2
78
Financing Cash Flow
1
3
2
2
188
1
3
12
-9
Change in Cash
13
1
-3
8
-6
2
15
-27
25

Edgewise Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-42
-67
-100
-133
-167
Operating Cash Flow
-14
-33
-52
-91
-109
-143
Investing Cash Flow
-24
-242
-70
102
-184
-32
Financing Cash Flow
120
186
129
53
249
196
Change in Cash
81
-89
6
64
-44
19

Mutual Funds that own Edgewise Therapeutics Stock

Check out the Mutual Funds with significant holdings in Edgewise Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.39809%
3690466
JANUS INVESTMENT FUND
1.311429%
1424267
Fidelity Select Portfolios
0.79235%
860525
American Century Mutual Funds, Inc.
0.78838%
856214
Fidelity Concord Street Trust
0.706507%
767296

Global Institutional Holdings in Edgewise Therapeutics

Funds
Holdings
Peter Kolchinsky
9.6%
Felix Baker
6.05%
Richard Driehaus
4.12%
Vanguard
4.12%
Joseph Edelman
4.07%

Insights on Edgewise Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, EWTX stock has moved up by 212.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 595.5% return, outperforming this stock by 71.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 460.9% return, outperforming this stock by 248.7%

About Edgewise Therapeutics

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials; and EDG-15400, a novel small molecule for the treatment of heart failure with preserved ejection fraction. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
OrganisationEdgewise Therapeutics
Headquarters1715 38th Street, Boulder, CO, United States, 80301
IndustryBiotechnology
CEODr. Kevin Koch Ph.D.
E-voting on sharesClick here to vote

Key Management of Edgewise Therapeutics

Name

Title

Dr. Behrad Derakhshan Ph.D.

Chief Operating Officer

Dr. Kevin Koch Ph.D.

President, CEO & Director

Dr. Badreddin Edris Ph.D.

Co-Founder & Independent Director

Dr. Alan J. Russell Ph.D.

Co-Founder, Chief Scientific Officer & Director

Mr. Michael P. Nofi

Chief Financial Officer

Dr. Joanne M. Donovan M.D., Ph.D.

Chief Medical Officer

Mr. John R. Moore J.D.

General Counsel

Dr. Aylin Tugcu

Senior Vice President of Cardiovascular Clinical Development & Medical Affairs

Dr. Peter A. Thompson FACP, M.D.

Co-Founder & Independent Chairman

FAQs

What is Edgewise Therapeutics share price today?

Edgewise Therapeutics share price today is $43.88 as on . Edgewise Therapeutics share today touched a day high of $43.98 and a low of $42.77.

What is the 52 week high and 52 week low for Edgewise Therapeutics share?

Edgewise Therapeutics share touched a 52 week high of $48.40 on and a 52 week low of $13.53 on . Edgewise Therapeutics stock price today i.e. is trending at $43.88,which is 9.34% down from its 52 week high and 224.44% up from its 52 week low.

What is Edgewise Therapeutics's market capitalisation today?

Edgewise Therapeutics market capitalisation is $0.00T as on .

How to invest in Edgewise Therapeutics Stock (EWTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Edgewise Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edgewise Therapeutics Shares that will get you 0.0342 shares as per Edgewise Therapeutics share price of $43.88 per share as on August 18, 2026 at 1:02 am IST.

What is the minimum amount required to buy Edgewise Therapeutics Stock (EWTX) from India?

Indian investors can start investing in Edgewise Therapeutics (EWTX) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in Edgewise Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Edgewise Therapeutics share’s latest price of $43.88 as on August 18, 2026 at 1:02 am IST, you will get 0.2279 shares of Edgewise Therapeutics. Learn more about fractional shares .

What are the returns that Edgewise Therapeutics has given to Indian investors in the last 5 years?

Edgewise Therapeutics stock has given 169.66% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?